| 1 |
34307188 | Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha. | 2021 |
1 |
| 2 |
34960758 | Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections. | 2021 Dec 11 |
1 |
| 3 |
32024338 | Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C. | 2020 Feb |
1 |
| 4 |
32346535 | Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment. | 2020 |
2 |
| 5 |
32885325 | A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNα + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress. | 2020 Dec |
1 |
| 6 |
30450781 | Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection. | 2019 Mar |
2 |
| 7 |
31081724 | Association of Autoantibody to Rods and Rings with Hepatitis C Outcome and Viral Load. | 2019 Jun |
1 |
| 8 |
31640596 | Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study. | 2019 Oct 22 |
1 |
| 9 |
31685739 | [QOL Assessment in Chronic Hepatitis C Patients Receiving Ledipasvir/ Sofosbuvir or Simeprevir/Peginterferon/Ribavirin in Clinical Practice]. | 2019 |
1 |
| 10 |
29272349 | Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes. | 2018 May 17 |
1 |
| 11 |
29293991 | Hepatitis C Virus-Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens. | 2018 Mar 13 |
2 |
| 12 |
29540601 | Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122. | 2018 Jun 1 |
3 |
| 13 |
29559835 | Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection. | 2018 |
1 |
| 14 |
29664167 | Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis. | 2018 May |
1 |
| 15 |
29851985 | Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. | 2018 |
6 |
| 16 |
29920131 | Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients. | 2018 Jun |
1 |
| 17 |
30063745 | Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis. | 2018 |
1 |
| 18 |
30116347 | Psychiatric side effects of pegylated interferon-α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta-analysis. | 2018 Aug |
1 |
| 19 |
27027531 | IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C. | 2017 Mar |
1 |
| 20 |
27896573 | Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin. | 2017 Apr |
1 |
| 21 |
28036111 | Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. | 2017 Jul |
1 |
| 22 |
28125694 | Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium. | 2017 |
1 |
| 23 |
28233734 | Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment. | 2017 March-April |
1 |
| 24 |
28315743 | Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. | 2017 Jul |
2 |
| 25 |
28496530 | Assessment of the Relation Between SNP in MxA Gene and the Responsiveness of Egyptian HCV Genotype 4 Patients to Pegylated Interferon and Ribavirin Treatment. | 2017 Apr |
1 |
| 26 |
28506030 | Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus. | 2017 Jul 15 |
1 |
| 27 |
29039351 | Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study. | 2017 Sep 25 |
1 |
| 28 |
29733167 | [Cytopenias and their correction during antiviral therapy of chronic hepatitis C in patients with genotype 1]. | 2017 |
1 |
| 29 |
26082258 | Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes. | 2016 Apr |
11 |
| 30 |
26750805 | Sustained viral response and treatment-induced cytopenia correlate with SLCs and KLF12 genotypes in interferon/ribavirin-treated Chinese chronic hepatitis C patients. | 2016 Aug |
1 |
| 31 |
26787701 | Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication. | 2016 Apr |
1 |
| 32 |
26825683 | Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens. | 2016 Feb |
2 |
| 33 |
26921346 | IFN-α promotes rapid human Treg contraction and late Th1-like Treg decrease. | 2016 Sep |
2 |
| 34 |
26945356 | Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir. | 2016 Mar |
1 |
| 35 |
27170384 | Challenges in Special Populations: HIV/HCV Coinfection, Liver Transplantation and Patients with End-Stage Renal Disease. | 2016 |
1 |
| 36 |
27275462 | Ophthalmological side effects of interferon therapy of chronic hepatitis C. | 2016 Jun |
2 |
| 37 |
27376688 | Optimisation of triple therapy for patients with chronic hepatitis C: a systematic review. | 2016 Aug |
2 |
| 38 |
27399090 | Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study. | 2016 Jul |
1 |
| 39 |
27857890 | Prevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapy. | 2016 Oct-Dec |
2 |
| 40 |
24961662 | Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study. | 2015 May |
1 |
| 41 |
25382001 | Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection. | 2015 Jun |
1 |
| 42 |
25445343 | Influence of amino acid variations in the NS3, NS4A and NS4B of HCV genotypes 1a, 1b, 3a, 3b and 6f on the response to pegylated interferon and ribavirin combination therapy. | 2015 Jan 22 |
1 |
| 43 |
25501286 | Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection. | 2015 Aug |
6 |
| 44 |
25515861 | Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C. | 2015 Mar |
1 |
| 45 |
25529083 | How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antivirals. | 2015 Jan |
2 |
| 46 |
25583751 | SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir. | 2015 Apr |
2 |
| 47 |
25624738 | Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report. | 2015 Jan 21 |
1 |
| 48 |
25650729 | Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplantation. | 2015 Apr |
1 |
| 49 |
25914454 | Management of hepatitis C infection before and after liver transplantation. | 2015 Apr 21 |
2 |
| 50 |
25920094 | From non-A, non-B hepatitis to hepatitis C virus cure. | 2015 Apr |
1 |